Experience symptoms of hormonal imbalance, such as fatigue or mood swings
The following adverse effects were reported in patients receiving semaglutide injection or oral tablets across all clinical trials and at incidences higher than with placebo: nausea (11% to 44%), vomiting (5% to 24%), diarrhea (8.5% to 30%), abdominal pain (5.7% to 20%), abdominal distention (2% to 7%), constipation (3.1% to 24%), dyspepsia (0.6% to 9%), decreased appetite (6% to 9%), eructation (0.6% to 7%), flatulence (0.4% to 6%), gastroesophageal reflux disease (1.5% to 5%), gastroenteritis (4% to 6%), and gastritis (0.4% to 4%)
Low levels have been linked with symptoms such as low mood, increased anxiety, irritability, and mood swings
You can either use a 1.2mL or 3mL syringe for a single injection, or split it into two equal injections of 60 units each at different sites